dc.contributor.author
Oertel, Frederike C.
dc.contributor.author
Paul, Friedemann
dc.date.accessioned
2022-12-07T14:11:57Z
dc.date.available
2022-12-07T14:11:57Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/37213
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-36925
dc.description.abstract
Neuromyelitis optica spectrum disorders are rare relapsing inflammatory central nervous system diseases with a heterogenous immunological and clinical spectrum.
International collaborations are required to:
(i) reach a better understanding of the disease and its subtypes;
(ii) develop laboratory and imaging biomarkers; and
(iii) ultimately improve treatments.
en
dc.rights.uri
https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject
neuromyelitis optica
en
dc.subject
diagnostic imaging
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Accelerating clinical research in neuromyelitis optica spectrum disorders
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.doi
10.1111/cen3.12637
dcterms.bibliographicCitation.journaltitle
Clinical and Experimental Neuroimmunology
dcterms.bibliographicCitation.number
2
dcterms.bibliographicCitation.originalpublishername
Wiley
dcterms.bibliographicCitation.pagestart
89
dcterms.bibliographicCitation.pageend
91
dcterms.bibliographicCitation.volume
12
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
DEAL Wiley
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.isPartOf.eissn
1759-1961
